| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 19 Dec 2025 | 15 Dec 2025 |
| Sudeep Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/12/2025 ,inter alia, to consider and approve Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended on September 30, 2025 and other Business items This is to inform you that the Board of Directors of the Company in their meeting held on Friday, 19th December 2025, inter alia, transacted the following business: Considered and approved the Unaudited Standalone & Consolidated Financial Results for the quarter and half year ended on 30th September 2025. (As per BSE Announcement dated on: 19.12.2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
